IOIのMARISOMEGA-3成分の範囲は、優れた製品をより健康的にするのに役立ち、心臓血管系と神経系にEPAとDHAのすべての十分に文書化された利点を提供します。 MARIS OMEGA-3は、革新的な製造技術を利用して「寿司のように新鮮」に製造され、最低の酸化レベルに到達します。味と匂いが100%ニュートラルなMARIS OMEGA-3は、食品用途に優れた官能特性と安定性を提供します。
オメガ3は、私たちの脳と心臓の機能、そして私たちの全体的な健康にとって重要な健康的な脂肪と見なされています。私たちの体はそれ自体でかなりのレベルでオメガ3を生成することができないので、結果として、私たちが毎日の食事でこのタイプの脂肪を消費することが不可欠です。オメガ3脂肪酸は、世界で最もよく研究されている栄養素の1つであり、過去35年間に30,000以上の科学的研究と発表された論文があり、オメガ3が出生前からあなたのシニア年に。オメガ3は、主に海産魚、藻類、特定の植物に含まれています。今日、魚はオメガ-3EPAとDHAの両方の主要な食事源であり、脂肪酸栄養素のダイナミックなデュオです。オメガ3エイコサペンタエン酸(EPA)とドコサヘキサエン酸(DHA)は、乳児の脳と目の発達から、成人と高齢者の心臓血管の健康の維持まで、身体のすべてのシステム全体の健康をサポートするのに役立ちます。フランスとドイツのオメガ3成分市場が主導するヨーロッパは、2017年から2023年にかけて毎年成長すると予想されています。アジア太平洋地域のオメガ3成分の市場規模は、個人消費の増加、人口の高齢化、および栄養補助食品アプリケーション全体の需要により、大幅に成長すると予想されます。中国と日本のオメガ3成分市場は、APACの地域的成長を主導し、中国が栄養補助食品の用途を支配しました。
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global EPA/DHA (Omega 3) Ingredients Market Size Growth Rate by Type (2020-2025)
1.3.2 Anchovy/Sardine
1.3.3 Cod Liver Oil
1.3.4 Salmon Oil
1.3.5 Algae Oil
1.3.6 High Concentrates
1.3.7 Medium Concentrates
1.3.8 Low Concentrates
1.4 Market Segment by Application
1.4.1 Global EPA/DHA (Omega 3) Ingredients Market Share by Application (2020-2025)
1.4.2 Dietary Supplements
1.4.3 Functional Foods
1.4.4 Pharmaceuticals
1.4.5 Pet & Animal Feed
1.4.6 Infant Formulas
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global EPA/DHA (Omega 3) Ingredients Market Size
2.1.1 Global EPA/DHA (Omega 3) Ingredients Revenue 2015-2025
2.1.2 Global EPA/DHA (Omega 3) Ingredients Sales 2015-2025
2.2 EPA/DHA (Omega 3) Ingredients Growth Rate by Regions
2.2.1 Global EPA/DHA (Omega 3) Ingredients Sales by Regions 2015-2019
2.2.2 Global EPA/DHA (Omega 3) Ingredients Revenue by Regions 2015-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 EPA/DHA (Omega 3) Ingredients Sales by Manufacturers
3.1.1 EPA/DHA (Omega 3) Ingredients Sales by Manufacturers 2015-2019
3.1.2 EPA/DHA (Omega 3) Ingredients Sales Market Share by Manufacturers 2015-2019
3.2 Revenue by Manufacturers
3.2.1 EPA/DHA (Omega 3) Ingredients Revenue by Manufacturers (2015-2019)
3.2.2 EPA/DHA (Omega 3) Ingredients Revenue Share by Manufacturers (2015-2019)
3.2.3 Global EPA/DHA (Omega 3) Ingredients Market Concentration Ratio (CR5 and HHI)
3.3 EPA/DHA (Omega 3) Ingredients Price by Manufacturers
3.4 Key Manufacturers EPA/DHA (Omega 3) Ingredients Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into EPA/DHA (Omega 3) Ingredients Market
3.6 Key Manufacturers EPA/DHA (Omega 3) Ingredients Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Anchovy/Sardine Sales and Revenue (2015-2019)
4.1.2 Cod Liver Oil Sales and Revenue (2015-2019)
4.1.3 Salmon Oil Sales and Revenue (2015-2019)
4.1.4 Algae Oil Sales and Revenue (2015-2019)
4.1.5 High Concentrates Sales and Revenue (2015-2019)
4.1.6 Medium Concentrates Sales and Revenue (2015-2019)
4.1.7 Low Concentrates Sales and Revenue (2015-2019)
4.2 Global EPA/DHA (Omega 3) Ingredients Sales Market Share by Type
4.3 Global EPA/DHA (Omega 3) Ingredients Revenue Market Share by Type
4.4 EPA/DHA (Omega 3) Ingredients Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global EPA/DHA (Omega 3) Ingredients Sales by Application
6 United States
6.1 United States EPA/DHA (Omega 3) Ingredients Breakdown Data by Company
6.2 United States EPA/DHA (Omega 3) Ingredients Breakdown Data by Type
6.3 United States EPA/DHA (Omega 3) Ingredients Breakdown Data by Application
7 European Union
7.1 European Union EPA/DHA (Omega 3) Ingredients Breakdown Data by Company
7.2 European Union EPA/DHA (Omega 3) Ingredients Breakdown Data by Type
7.3 European Union EPA/DHA (Omega 3) Ingredients Breakdown Data by Application
8 China
8.1 China EPA/DHA (Omega 3) Ingredients Breakdown Data by Company
8.2 China EPA/DHA (Omega 3) Ingredients Breakdown Data by Type
8.3 China EPA/DHA (Omega 3) Ingredients Breakdown Data by Application
9 Rest of World
9.1 Rest of World EPA/DHA (Omega 3) Ingredients Breakdown Data by Company
9.2 Rest of World EPA/DHA (Omega 3) Ingredients Breakdown Data by Type
9.3 Rest of World EPA/DHA (Omega 3) Ingredients Breakdown Data by Application
9.4 Rest of World EPA/DHA (Omega 3) Ingredients Breakdown Data by Countries
9.4.1 Rest of World EPA/DHA (Omega 3) Ingredients Sales by Countries
9.4.2 Rest of World EPA/DHA (Omega 3) Ingredients Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Omega Protein
10.1.1 Omega Protein Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of EPA/DHA (Omega 3) Ingredients
10.1.4 EPA/DHA (Omega 3) Ingredients Product Introduction
10.1.5 Omega Protein Recent Development
10.2 DSM
10.2.1 DSM Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of EPA/DHA (Omega 3) Ingredients
10.2.4 EPA/DHA (Omega 3) Ingredients Product Introduction
10.2.5 DSM Recent Development
10.3 BASF
10.3.1 BASF Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of EPA/DHA (Omega 3) Ingredients
10.3.4 EPA/DHA (Omega 3) Ingredients Product Introduction
10.3.5 BASF Recent Development
10.4 Axellus
10.4.1 Axellus Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of EPA/DHA (Omega 3) Ingredients
10.4.4 EPA/DHA (Omega 3) Ingredients Product Introduction
10.4.5 Axellus Recent Development
10.5 Martek
10.5.1 Martek Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of EPA/DHA (Omega 3) Ingredients
10.5.4 EPA/DHA (Omega 3) Ingredients Product Introduction
10.5.5 Martek Recent Development
10.6 Aker BioMarine
10.6.1 Aker BioMarine Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of EPA/DHA (Omega 3) Ingredients
10.6.4 EPA/DHA (Omega 3) Ingredients Product Introduction
10.6.5 Aker BioMarine Recent Development
10.7 Algae EPAX
10.7.1 Algae EPAX Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of EPA/DHA (Omega 3) Ingredients
10.7.4 EPA/DHA (Omega 3) Ingredients Product Introduction
10.7.5 Algae EPAX Recent Development
10.8 Lonza
10.8.1 Lonza Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of EPA/DHA (Omega 3) Ingredients
10.8.4 EPA/DHA (Omega 3) Ingredients Product Introduction
10.8.5 Lonza Recent Development
10.9 GC Rieber Oils
10.9.1 GC Rieber Oils Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of EPA/DHA (Omega 3) Ingredients
10.9.4 EPA/DHA (Omega 3) Ingredients Product Introduction
10.9.5 GC Rieber Oils Recent Development
10.10 Croda
10.10.1 Croda Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of EPA/DHA (Omega 3) Ingredients
10.10.4 EPA/DHA (Omega 3) Ingredients Product Introduction
10.10.5 Croda Recent Development
12 Market Forecast
12.1 Global EPA/DHA (Omega 3) Ingredients Sales and Revenue Forecast 2020-2025
12.2 Global EPA/DHA (Omega 3) Ingredients Sales Forecast by Type
12.3 Global EPA/DHA (Omega 3) Ingredients Sales Forecast by Application
12.4 EPA/DHA (Omega 3) Ingredients Forecast by Regions
12.4.1 Global EPA/DHA (Omega 3) Ingredients Sales Forecast by Regions 2020-2025
12.4.2 Global EPA/DHA (Omega 3) Ingredients Revenue Forecast by Regions 2020-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer